Projects per year
Fingerprint
Dive into the research topics where Kristoff Muylle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
Research output
-
18F-FDG PET/CT findings in an adult with diffuse hemangiomatosis mimicking diffuse metastasis on conventional radiology
Ardies, P. J., Muylle, K., Everaert, H., Goethals, L., Gykiere, P., Keyaerts, M. & Lahoutte, T., 5 May 2017.Research output: Unpublished contribution to conference › Poster
-
PET 20.0: a cost-efficient, 2mm spatial resolution Total Body PET with point sensitivity up to 22% and adaptive axial FOV of maximum 2.00m
Vandenberghe, S., Mikhalyova, E., Brans, B., Defrise, M., Lahoutte, T., Muylle, K., Van Holen, R., Schaart, D. R. & Karp, K. S., Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, p. S305-S305Research output: Contribution to journal › Meeting abstract (Journal)
3 Citations (Scopus) -
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Muylle, K., Flamen, P., Vugts, D. J., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, G. A. M. S., Everaert, H., Vaes, M. & Bron, D., Jul 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, 8, p. 1304-1314 11 p.Research output: Contribution to journal › Article
48 Citations (Scopus) -
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
Muylle, K., Flamen, P., Vugts, DJ., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, GAMS., Everaert, H., Vaes, M. & Bron, D., 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, p. 1304-1314Research output: Contribution to journal › Article
-
Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2
Covens, P., Jamar, F. & Muylle, K., Mar 2014, HGR/CSS ed. FOD Volksgezonheid, Veiligheid van de voedselketen en leefmilieu. 15 p.Research output: Book/Report › Commissioned report
Open Access
-
-
2017 BELNUC Highlights Lecture
Kristoff Muylle (Invited speaker)7 May 2017Activity: Talk or presentation › Talk or presentation at a conference